prior to now several years, the UK has witnessed a revolution in health-related pounds‑decline solutions — in the introduction of semaglutide (Wegovy®) towards the escalating attractiveness of tirzepatide (Mounjaro®). Now, An additional identify is drawing focus in the two clinical and general pu